Add Company
Join Now

CinCor Pharma Revenue and Competitors

License our Company Data API

Location

$193M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • CinCor Pharma's estimated annual revenue is currently $1M per year.(i)
  • CinCor Pharma's estimated revenue per employee is $77,500
  • CinCor Pharma's total funding is $193M.

Employee Data

  • CinCor Pharma has 13 Employees.(i)
  • CinCor Pharma grew their employee count by -58% last year.

CinCor Pharma's People

NameTitleEmail/Phone
1
Staff AccountantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.8M50%N/AN/A
#2
$1.7M110%N/AN/A
#3
$0.8M50%N/AN/A
#4
$5.1M3314%N/AN/A
#5
$64.6M4172%N/AN/A
#6
$1.7M11-8%N/AN/A
#7
$0.8M50%N/AN/A
#8
$7.4M48-41%N/AN/A
#9
$0.6M40%N/AN/A
#10
$0.9M1220%N/AN/A
Add Company

What Is CinCor Pharma?

DEVELOPING THE NEXT GENERATION OF TREATMENTS FOR CARDIOVASCULAR DISEASES.

keywords:N/A

$193M

Total Funding

13

Number of Employees

$1M

Revenue (est)

-58%

Employee Growth %

N/A

Valuation

N/A

Accelerator

CinCor Pharma News

2022-04-17 - The Treatment-resistant Hypertension Market to Grow ...

Key Treatment-resistant Hypertension companies such as Idorsia Ltd, Janssen Biotech, Quantum Genomics SA, CinCor Pharma, Ionis Pharmaceuticals,...

2022-04-17 - The Treatment-resistant Hypertension Market to Grow ...

... CinCor Pharmaduring, and others the forecast period (2019–2032). ... Quantum Genomics SA, CinCor Pharma, Ionis Pharmaceuticals,...

2022-03-30 - We're Hopeful That CinCor Pharma (NASDAQ:CINC) Will Use Its Cash Wisely

When CinCor Pharma last reported its balance sheet in December 2021, it had zero debt and cash worth US$137m. Importantly, its cash burn was US...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.5M13-38%N/A
#2
$0.5M1344%N/A
#3
$2.1M130%N/A
#4
$1.9M13-7%N/A
#5
$1.6M13-24%N/A